Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders
ECHION
1 other identifier
interventional
86
1 country
1
Brief Summary
The proposed clinical trial aims to examine the efficacy of an online-based self-help intervention for auditory hallucinations in persons with psychotic disorders. The intervention is primarily based on Metacognitive Training (MKT) and Mindfulness-Based Group Therapy (MBGT). The investigators will utilize a mixed-method study design within a randomized controlled trial. The intervention group will be compared with a waitlist-control group (WL-TAU). Both study conditions are allowed to continue standard scheduled treatment. The aim is to analyze the efficacy of and the subjective satisfaction with the intervention, based on self-report assessments evaluated from baseline (T0) to post-intervention after 6 weeks (T1).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2023
CompletedFirst Posted
Study publicly available on registry
January 2, 2024
CompletedStudy Start
First participant enrolled
June 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedJune 14, 2024
June 1, 2024
1.1 years
December 5, 2023
June 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency and distress of auditory hallucinations, PSYRATS
The frequency and distress of auditory hallucinations measured by the hallucination subscale of the Psychotic Symptom Rating Scales (PSYRATS). Comparison between the intervention and control group, considering changes from baseline to post-intervention.
At baseline and post-intervention at week 6 (T1).
Secondary Outcomes (6)
Beliefs about voices, BAVQ-R
At baseline (T0) and post-intervention at week 6 (T1).
Hallucinatory experiences, LSHS-R
At baseline (T0) and post-intervention at week 6 (T1).
Negative Symptoms, SNS
At baseline (T0) and post-intervention at week 6 (T1).
Positive and Negative Affect, PANAS
At baseline (T0) and post-intervention at week 6 (T1).
Characteristics of Voices, Thinking Scale
At baseline (T0) and post-intervention at week 6 (T1).
- +1 more secondary outcomes
Study Arms (2)
Online-Based Self-Help Intervention
EXPERIMENTALThe online-based self-help intervention is implemented as a six-week self-help intervention that is primarily based on Metacognitive Training (MKT), Mindfulness-Based Group Therapy (MBGT), and elements of cognitive behavioural therapy. It is conducted online and includes worksheets, audio, and interactive files. Participants work themselves through the intervention, based on their own needs and speed. All participants are allowed to continue parallel implemented standard scheduled treatment (TAU; for a description of TAU, see the section below).
Waitlist-Control Group
NO INTERVENTIONThe waitlist control group will not receive any additional intervention but is allowed to continue standard scheduled treatment (WL-TAU). This includes various forms of psychotherapeutic, pharmacologic, psychosocial, online, and other self-help interventions, either carried out individually or within a group. After study completion, participants in the waitlist-control group will equally receive the online-based self-help intervention.
Interventions
See the description above.
Eligibility Criteria
You may qualify if:
- current experience of auditory hallucinations that appear at least once a week (measured over the PSYRATS).
- diagnosis of a schizophrenia-spectrum disorder according to the Diagnostical and Statistical Manual (5th edition) and/or the International Statistical Classification of Diseases and Related Health Problems (ICD-10), code F2x.x. In case of a suspected diagnosis or missing clinical diagnostic, we will apply the Mini-International Neuropsychiatric Interview (M.I.N.I.).
- stable psychiatric medication over at least one month, slight changes of dosage are allowed and will be evaluated by a trained psychiatrist.
- ability to give informed consent.
- willingness and ability to engage in the psychotherapeutic self-help intervention.
- availability of a mobile device and internet access.
You may not qualify if:
- neurological disorders that may affect cognitive functioning and condition after severe traumatic brain injury.
- acute suicidality, assessed at the previous screening procedures.
- auditory hallucinations in the context of other primary diagnoses e.g., post-traumatic stress disorder or borderline personality disorder.
- acute substance abuse other than nicotine and prescribed medication.
- current electroconvulsive therapy.
- current inpatient or day-care treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin
Berlin, 12203, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 5, 2023
First Posted
January 2, 2024
Study Start
June 13, 2024
Primary Completion
July 15, 2025
Study Completion
December 15, 2025
Last Updated
June 14, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share